These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 32506767)

  • 1. MiR-145 in cancer therapy resistance and sensitivity: A comprehensive review.
    Xu W; Hua Y; Deng F; Wang D; Wu Y; Zhang W; Tang J
    Cancer Sci; 2020 Sep; 111(9):3122-3131. PubMed ID: 32506767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-155 in cancer drug resistance and as target for miRNA-based therapeutics.
    Bayraktar R; Van Roosbroeck K
    Cancer Metastasis Rev; 2018 Mar; 37(1):33-44. PubMed ID: 29282605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.
    Humphries B; Yang C
    Oncotarget; 2015 Mar; 6(9):6472-98. PubMed ID: 25762624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
    Vo DT; Karanam NK; Ding L; Saha D; Yordy JS; Giri U; Heymach JV; Story MD
    Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-21: a novel therapeutic target in human cancer.
    Pan X; Wang ZX; Wang R
    Cancer Biol Ther; 2010 Dec; 10(12):1224-32. PubMed ID: 21139417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamically decreased miR-671-5p expression is associated with oncogenic transformation and radiochemoresistance in breast cancer.
    Tan X; Li Z; Ren S; Rezaei K; Pan Q; Goldstein AT; Macri CJ; Cao D; Brem RF; Fu SW
    Breast Cancer Res; 2019 Aug; 21(1):89. PubMed ID: 31391072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-21, An Oncogenic Target miRNA for Cancer Therapy: Molecular Mechanisms and Recent Advancements in Chemo and Radio-resistance.
    Javanmardi S; Aghamaali MR; Abolmaali SS; Mohammadi S; Tamaddon AM
    Curr Gene Ther; 2017; 16(6):375-389. PubMed ID: 28042781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The miR-15a/16 gene cluster in human cancer: A systematic review.
    Liu T; Xu Z; Ou D; Liu J; Zhang J
    J Cell Physiol; 2019 May; 234(5):5496-5506. PubMed ID: 30246332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-217: A regulator of human cancer.
    Zhou S; Zhu C; Pang Q; Liu HC
    Biomed Pharmacother; 2021 Jan; 133():110943. PubMed ID: 33254014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-214: a potential biomarker and therapeutic for different cancers.
    Sharma T; Hamilton R; Mandal CC
    Future Oncol; 2015; 11(2):349-63. PubMed ID: 25591843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-221: biogenesis, function and signatures in human cancers.
    Abak A; Amini S; Sakhinia E; Abhari A
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3094-3117. PubMed ID: 29863255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Tumor Suppressor Roles and Mechanisms of MiR-491 in Human Cancers.
    Sadri F; Hosseini SF; Aghayei A; Fereidouni M; Rezaei Z
    DNA Cell Biol; 2022 Sep; 41(9):810-823. PubMed ID: 35914029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of miRNA-based therapeutic approaches for cancer patients.
    Takahashi RU; Prieto-Vila M; Kohama I; Ochiya T
    Cancer Sci; 2019 Apr; 110(4):1140-1147. PubMed ID: 30729639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
    Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
    Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
    Schliesser MG; Claus R; Hielscher T; Grimm C; Weichenhan D; Blaes J; Wiestler B; Hau P; Schramm J; Sahm F; Weiß EK; Weiler M; Baer C; Schmidt-Graf F; Schackert G; Westphal M; Hertenstein A; Roth P; Galldiks N; Hartmann C; Pietsch T; Felsberg J; Reifenberger G; Sabel MC; Winkler F; von Deimling A; Meisner C; Vajkoczy P; Platten M; Weller M; Plass C; Wick W
    Oncotarget; 2016 Dec; 7(50):82028-82045. PubMed ID: 27880937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
    Zhang X; Huang L; Zhao Y; Tan W
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7.
    Zhou X; Jin W; Jia H; Yan J; Zhang G
    J Exp Clin Cancer Res; 2015 Mar; 34(1):28. PubMed ID: 25888377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation.
    Ishimoto T; Sugihara H; Watanabe M; Sawayama H; Iwatsuki M; Baba Y; Okabe H; Hidaka K; Yokoyama N; Miyake K; Yoshikawa M; Nagano O; Komohara Y; Takeya M; Saya H; Baba H
    Carcinogenesis; 2014 May; 35(5):1003-11. PubMed ID: 24318997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-130a modulates a radiosensitivity of rectal cancer by targeting SOX4.
    Ha Thi HT; Kim HY; Kim YM; Hong S
    Neoplasia; 2019 Sep; 21(9):882-892. PubMed ID: 31387015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
    Jiao X; Zhao L; Ma M; Bai X; He M; Yan Y; Wang Y; Chen Q; Zhao X; Zhou M; Cui Z; Zheng Z; Wang E; Wei M
    Breast Cancer Res Treat; 2013 Jun; 139(3):717-30. PubMed ID: 23780685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.